Skip to main content
. 2010 May 25;4:493–517. doi: 10.2147/opth.s8980

Table 3.

Search: Embase®

  1. randomized controlled trial.pt.

  2. (randomized or randomised).ab,ti.

  3. placebo.ab,ti.

  4. randomly.ab,ti.

  5. trial.ab,ti.

  6. groups.ab,ti.

  7. dt.fs.

  8. or/1–7

  9. exp animals/

  10. exp humans/

  11. 9 not (9 and 10)

  12. 8 not 11

  13. clinical trial.pt

  14. cluster trial

  15. exp control group

  16. double blind$.tw

  17. single blind$.tw

  18. (blind$ or mask$).tw

  19. exp cross over

  20. exp comparative study

  21. prospective$.tw

  22. or 13–21

  23. or 12–22

  24. angiogenes$.tw.

  25. exp angiogenesis inhibitors/

  26. exp angiogenic factor/

  27. endothelial cell growth facto$.tw.

  28. exp vasculotropin/

  29. (macugen$ or pegaptanib$ or lucentis$ or rhufab$ or ranibizumab$ or bevacizumab$).tw.

  30. (anti adj2 VEGF$).tw.

  31. (endothelial adj2 growth adj2 factor$).tw.

  32. exp angiogenesis inducing agents/

  33. or 24–32

  34. exp diabetic retinopathy/

  35. exp macular edema cystoid/

  36. exp macular degeneration/

  37. (macula$ adj2 edema).tw.

  38. (macula$ adj2 edema).tw.

  39. DME.tw.

  40. DMO.tw.

  41. CME.tw.

  42. CSME.tw.

  43. (macula$ adj2 swell$).tw.

  44. microaneurysm$.tw.

  45. (dilat$ adj2 capillar$).tw.

  46. or 34–45

  47. 23 and 33 and 46